Cirius Therapeutics Expands Board of Directors with Appointment of Elaine D. Sun

December 13, 2018 – Cirius Therapeutics announced today that Elaine D. Sun, M.B.A., has been appointed to the company’s board of directors as an independent director.

Read On ›

NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs

November 5, 2018 – NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced today that it has completed a $25 […]

Read On ›

Cirius Therapeutics Reports Positive Data for MSDC-0602K in Interim Analysis of Phase 2b Clinical Trial in NASH Patients with Fibrosis

October 25, 2018 - Cirius Therapeutics today announced positive results from an interim analysis of exploratory endpoints from its ongoing, fully enrolled Phase 2b clinical trial (the EMMINENCE trial) evaluating MSDC-0602K in 402 patients diagnosed with […]

Read On ›